Ingredent :- Voglibose 0.2mg + Glimepiride 2mg + Metformin Hydrochloride 500mg (sustained release)
Used for :- VOGLI GM 2 TABLET – Used for controlling blood sugar levels in type 2 diabetes mellitus.
Packing of 10 tablets strip
1. Indications
– Type 2 Diabetes Mellitus: VOGLI GM 2 TABLET is used to control blood glucose levels in patients with type 2 diabetes, either as monotherapy or in combination with other antidiabetic medications.
– Insulin Resistance: It assists in improving insulin sensitivity in patients whose bodies do not respond well to insulin.
– Combination Therapy: In some cases, VOGLI GM 2 TABLET is prescribed alongside other diabetes medications or insulin to enhance blood sugar control and achieve better overall management.
2. Benefits
The key benefits of VOGLI GM 2 TABLET include:
– Enhanced Insulin Sensitivity: By improving the body’s response to insulin, VOGLI GM 2 TABLET helps lower blood sugar levels effectively.
– Reduction of Blood Glucose: It helps reduce both fasting blood glucose levels and post-meal glucose levels, contributing to better overall control of diabetes.
– Prevention of Complications: Effective blood sugar control with VOGLI GM 2 TABLET can help prevent diabetes-related complications, including cardiovascular issues, nerve damage, and kidney disease.
3. Dosage and Administration
For optimal results, VOGLI GM 2 TABLET should be taken according to the doctor’s instructions. Typical guidelines include:
– Standard Dosage: The usual dose is one tablet per day, taken with food to reduce the risk of gastrointestinal side effects. Dosage adjustments may be made based on individual blood sugar levels and response to treatment.
– How to Take: Swallow the tablet whole with a glass of water. Avoid chewing or breaking the tablet.
– Missed Dose: If a dose is missed, take it as soon as you remember unless it’s close to the time for the next dose. In that case, skip the missed dose and resume the regular dosing schedule.
4. Mechanism of Action
VOGLI GM 2 TABLET works by improving insulin sensitivity and reducing the production of glucose in the liver. It also helps to increase glucose uptake by the muscles, which leads to lower blood glucose levels. This action helps the body to regulate blood sugar more effectively and reduces the burden on the pancreas.
5. Side Effects
While side effects are not common, some may occur, including:
– Gastrointestinal Issues: Symptoms like bloating, nausea, or diarrhea may occur when starting VOGLI GM 2 TAB.
– Low Blood Sugar: When combined with other medications, VOGLI GM 2 TABLET may cause hypoglycemia, especially if the person does not eat regularly or engages in intense physical activity.
– Skin Reactions: In rare cases, skin rashes or allergic reactions may occur. If any unusual symptoms are observed, contact a healthcare provider immediately.
6. Precautions
Certain precautions should be followed before using VOGLI GM 2 TAB:
– Kidney or Liver Disease: Patients with pre-existing kidney or liver issues should discuss the use of VOGLI GM 2 TABLET with their healthcare provider, as the dosage may need to be adjusted.
– Drug Interactions: Other medications, especially those for high blood pressure or cholesterol, may interact with VOGLI GM 2 TAB. Be sure to inform the doctor about all other medications being used.
– Pregnancy and Breastfeeding: The safety of VOGLI GM 2 TABLET during pregnancy or breastfeeding is not well-established, so it’s important to consult a doctor before starting the medication during these periods.
7. Conclusion
In conclusion, VOGLI GM 2 TABLET provides an effective solution for managing type 2 diabetes by improving insulin sensitivity and regulating blood glucose levels. It is an important part of a comprehensive diabetes management plan, which includes diet, exercise, and regular monitoring of blood sugar. By following the prescribed dosage and consulting regularly with a healthcare provider, patients can significantly reduce their risk of complications and improve their overall health and quality of life.






Reviews
There are no reviews yet.